<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>In vitro and in vivo studies</italic> - Genome and replication kinetics of SARS-CoV, MERS-CoV and SARS-CoV-2 viruses are very similar, suggesting that these diseases could be treated by a single drug that modulates the activity of a common target or mechanism among them.
 <xref rid="B52" ref-type="bibr">
  <sup>52</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B186" ref-type="bibr">
  <sup>186</sup>
 </xref> So far, no clinically available antiviral drugs have been developed for any of these three viruses.
 <xref rid="B187" ref-type="bibr">
  <sup>187</sup>
 </xref> This fact demonstrates that we did not learn a suitable strategy for treatment from these two prior diseases, and we are not yet prepared to deal with this new coronavirus epidemic, regarding therapeutic options.
 <xref rid="B188" ref-type="bibr">
  <sup>188</sup>
 </xref>
</p>
